HomeComparePBIGF vs NNN

PBIGF vs NNN: Dividend Comparison 2026

PBIGF yields 1111.11% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PBIGF wins by $47499206.05M in total portfolio value
10 years
PBIGF
PBIGF
● Live price
1111.11%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47499206.07M
Annual income
$40,354,669,257,990.61
Full PBIGF calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — PBIGF vs NNN

📍 PBIGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPBIGFNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PBIGF + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PBIGF pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PBIGF
Annual income on $10K today (after 15% tax)
$94,444.44/yr
After 10yr DRIP, annual income (after tax)
$34,301,468,869,292.02/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, PBIGF beats the other by $34,301,468,867,050.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PBIGF + NNN for your $10,000?

PBIGF: 50%NNN: 50%
100% NNN50/50100% PBIGF
Portfolio after 10yr
$23749603.05M
Annual income
$20,177,334,630,314.02/yr
Blended yield
84.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

PBIGF
No analyst data
Altman Z
-20.2
Piotroski
2/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PBIGF buys
0
NNN buys
0
No recent congressional trades found for PBIGF or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPBIGFNNN
Forward yield1111.11%5.68%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$47499206.07M$25.6K
Annual income after 10y$40,354,669,257,990.61$2,637.42
Total dividends collected$46960998.57M$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PBIGF vs NNN ($10,000, DRIP)

YearPBIGF PortfolioPBIGF Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$121,811$111,111.11$10,737$617.02+$111.1KPBIGF
2$1,395,251$1,264,912.89$11,577$710.93+$1.38MPBIGF
3$15,033,652$13,540,734.05$12,538$822.59+$15.02MPBIGF
4$152,440,880$136,354,872.42$13,645$956.06+$152.43MPBIGF
5$1,455,294,162$1,292,182,420.27$14,925$1,116.51+$1455.28MPBIGF
6$13,086,105,030$11,528,940,276.13$16,415$1,310.57+$13086.09MPBIGF
7$110,889,069,345$96,886,936,963.27$18,158$1,546.77+$110889.05MPBIGF
8$885,941,741,006$767,290,436,806.24$20,213$1,836.20+$885941.72MPBIGF
9$6,677,137,211,537$5,729,179,548,660.89$22,649$2,193.37+$6677137.19MPBIGF
10$47,499,206,074,335$40,354,669,257,990.61$25,558$2,637.42+$47499206.05MPBIGF

PBIGF vs NNN: Complete Analysis 2026

PBIGFStock

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

Full PBIGF Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this PBIGF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PBIGF vs SCHDPBIGF vs JEPIPBIGF vs OPBIGF vs KOPBIGF vs MAINPBIGF vs ADCPBIGF vs EPRTPBIGF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.